HD Medical Signs Distribution Agreement with Stethoscope.com for HD Steth Intelligent Stethoscope with Integrated ECG

HD Medical, Inc., today announces that it has launched online sales for its flagship product,  HD Steth™, via Stethoscope.com, a leading online stethoscope and medical product distributor.

HD Medical recently signed Stethoscope.com as a cornerstone U.S. online distribution partner. HD Steth addresses the cardiac monitoring, specialist reporting, and global stethoscope markets for both medical and veterinary applications.

In July 2020, HD Steth received FDA clearance for all three product classification codes of DQD, DQC and DPS for Electronic Stethoscope, Phonocardiograph and Electrocardiograph combined into one device. HD Steth enables clinicians to capture, record, replay, and visualize heart sounds and ECG waveforms simultaneously on a smart device to help detect multiple cardiac abnormalities. HD Steth provides patented high-definition visualization and noise-cancellation technologies that allow clinicians to see and hear subtle heart sound that are often difficult or impossible to detect during auscultation. Patient data can be saved and shared with a specialist for remote diagnosis and a second opinion.

“We welcome HD Medical’s HD Steth to our Stethoscope.com line-up – we see high demand for intelligent stethoscopes that do more than just auscultation. HD Steth’s integrated ECG, connectivity, and intelligent visualization deliver instant cardiac insights at the point-of-care and for Tele-Health.” according to a Stethoscope.com spokesperson.

“HD Steth is the most versatile and powerful intelligent stethoscope I’ve ever used during my decades of practice. The sound quality is spectacular and the best amongst all other stethoscopes. The ability to immediately see and hear subtle heart sounds alongside ECG waveforms enables clinicians to detect abnormalities quickly and with assurance,” says Dr. Nelson B. Schiller, MD, FACC, FRCP at UCSF.

“We are pleased to be on board with Stethoscope.com – we consider them leaders in the stethoscope market. Our two companies are embarking on a long relationship with a mission of bringing high quality cardiac care solutions to the market in an effort to helping medical professionals to save more lives.” said Arvind Thiagarajan, Founder and CEO of HD Medical, Inc.

HD Steth is available for sale through Stethoscope.com. The HD Steth App is available for Apple iOS and Android at Apple’s App Store and Google Play Store, respectively.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version